Saranas® Expands Intellectual Property with Key Patent Integrating Bleed Monitoring and Vascular Access Closure Device
Retrieved on:
Wednesday, February 23, 2022
Biotechnology, Surgery, Medical Devices, Hospitals, Health, Physician, Patent, Hemostasis, Failure, Early Bird, Use of Free and Open-Source Software (FOSS) in the U.S. Department of Defense, The Early Bird, Research, Femoral artery, USPTO, Aortic valve, Medical director, Bleeding, Internal bleeding, Patent ductus arteriosus, FDA, The Christ Hospital, Carl, TAVR, Technology, Standard of care, Birth control, Medical imaging, Sarana Chatushtai, the Early Bird Bleed Monitoring System, Saranas, THE EARLY BIRD BLEED MONITORING SYSTEM, SARANAS
Titled Access Closure with Bleed Monitoring, this key patent allows for embedding a vascular access closure device with the companys proprietary bleed monitoring technology.
Key Points:
- Titled Access Closure with Bleed Monitoring, this key patent allows for embedding a vascular access closure device with the companys proprietary bleed monitoring technology.
- Saranas Early Bird Bleed Monitoring System is the first and only FDA-approved device for real-time detection and monitoring of endovascular bleed complications.
- This patent award demonstrates Saranas commitment to innovation and further strengthens our intellectual property portfolio.
- The Early Bird Bleed Monitoring System includes a bleed detection array with integrated electrodes in a fully functional vascular access sheath.